Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24-month study

Pediatr Dent. 2011 Mar-Apr;33(2):165-70.

Abstract

Purpose: The purpose of this study was to evaluate the total success rates of mineral trioxide aggregate (MTA), ferric sulfate (FS), and formocresol (FC) as pulpotomy agents in primary molars.

Methods: A randomized, split-mouth study design was used in 32 healthy 5- to 7-year-old children with 128 carious primary molars without clinical or radiographic evidence of pulp degeneration. The pulpotomy agents were assigned as follows: Group 1=MTA; Group 2=FS; Group 3=1:5 diluted Buckley's FC; and Group 4=zinc oxide eugenol (ZOE) base. Clinical and radiographic follow-up at 6, 12, and 24 months used the following criteria: pain; swelling; sinus tract; mobility; internal root resorption; and furcation and/or periapical bone destruction. The data were analyzed using chi-square.

Results: No significant differences in success rates were found among the groups at 6 and 12 months. Success rates in groups 1 to 4 at 24 months were 96%, 88%, 88%, and 68% respectively. There was a significant difference (P<.001) between the MTA and ZOE groups at 24 months.

Conclusions: ZOE, as the only pulpotomy medicament, had a significantly lower success rate than MTA. No significant differences were observed, among the 3 experimental materials (MTA, FC, and FS) at 2 years follow-up.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aluminum Compounds / therapeutic use*
  • Calcium Compounds / therapeutic use*
  • Child
  • Child, Preschool
  • Dental Amalgam
  • Dental Caries / therapy
  • Dental Fistula / etiology
  • Dental Restoration, Permanent / methods
  • Drug Combinations
  • Edema / etiology
  • Female
  • Ferric Compounds / therapeutic use*
  • Follow-Up Studies
  • Formocresols / therapeutic use*
  • Furcation Defects / etiology
  • Humans
  • Male
  • Molar / drug effects
  • Oxides / therapeutic use*
  • Periapical Diseases / etiology
  • Pulp Capping and Pulpectomy Agents / therapeutic use*
  • Pulpotomy / methods*
  • Root Resorption / etiology
  • Silicates / therapeutic use*
  • Single-Blind Method
  • Tooth Mobility / etiology
  • Tooth, Deciduous / drug effects
  • Toothache / etiology
  • Treatment Outcome
  • Zinc Oxide-Eugenol Cement / therapeutic use

Substances

  • Aluminum Compounds
  • Calcium Compounds
  • Drug Combinations
  • Ferric Compounds
  • Formocresols
  • Oxides
  • Pulp Capping and Pulpectomy Agents
  • Silicates
  • Zinc Oxide-Eugenol Cement
  • mineral trioxide aggregate
  • formocresol
  • ferric sulfate
  • Dental Amalgam